查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541515

2024-2032 年口干症治疗市场报告（按类型、药物类型、配销通路和地区）

Xerostomia Therapeutics Market Report by Type, Drug Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023年，IMARC Group口干症（口干症）治疗市场规模达7.398亿美元。 % 。

口干症或口干是指口腔干燥的症状或感觉，通常是由于唾液量减少引起的。这种情况是由颈部和头部放射性的不利影响、抗焦虑药物的消耗增加、脱水、糖尿病和阿兹海默症引发的。可以透过唾液笔或兴奋剂、人工唾液、处方药物和家庭疗法（包括喝水和滋润嘴唇）来治疗。除此之外，医生对唾液腺的早期诊断和使用推荐的口腔保湿产品（例如非处方（OTC）漱口水）可以帮助润滑口腔。这些治疗可缓解不适，预防严重併发症，修復味觉障碍，并减轻口臭和味觉障碍。因此，一些医院和诊所使用口干疗法来治疗唾液腺功能下降。

口干症（口干症）治疗市场趋势：

由于放射治疗和化疗的药物副作用，口干的发生率不断增加，特别是在老年人群中，以及对口干缓解产品的需求不断增加，主要推动了市场的成长。此外，一些处方牙膏、维生素软糖和治疗干燥综合症、阿兹海默症和导致口干症的人类免疫缺陷病毒 (HIV) 的药物的使用量不断增加，也是另一个生长诱导因素。与此一致的是，消费者对口干症早期诊断意识的不断提高、医疗保健支出的显着增加以及多样化诊断技术的出现正在推动市场成长。此外，政府为提高消费者对口干症及其症状、原因和治疗的认识而采取的有利倡议正在推动市场成长。除此之外，各种治疗药物的容易取得以及持续的研发（R＆D）活动正在为市场创造积极的前景。

本报告回答的关键问题

  • 全球口干症（口干症）治疗市场有多大？ 2024-2032年全球口干症（口干症）治疗市场的预期成长率为何？
  • 推动全球口干症（口干症）治疗市场的关键因素是什么？
  • COVID-19 对全球口干症（口干症）治疗市场有何影响？
  • 全球口干症（口干病）治疗市场按类型划分是怎样的？
  • 根据药物类型，全球口干症（口干症）治疗市场的细分情况如何？
  • 基于配销通路，全球口干症（口干病）治疗市场的细分情况如何？
  • 全球口干症（口干症）治疗市场的关键区域有哪些？
  • 谁是全球口干症（口干病）治疗市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球口干症（口干病）治疗市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 人工唾液/唾液替代品
    • 市场趋势
    • 市场预测
  • 唾液兴奋剂
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按药物类型

  • 场外交易
    • 市场趋势
    • 市场预测
  • 处方
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场趋势
    • 市场预测
  • 零售药房
    • 市场趋势
    • 市场预测
  • 网路药房
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Biotene (GSK plc)
    • Parnell Pharmaceuticals Inc.
    • Quest Products LLC
    • Saliwell Ltd
    • Sun Pharmaceutical Industries Limited
    • West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
Product Code: SR112024A6439

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032.

Xerostomia, or dry mouth, refers to symptoms or sensations of oral dryness that are usually caused due to a decrease in the amount of saliva. This condition is triggered by the adverse effects of radioactivity in the neck and head, increasing consumption of antianxiety drugs, dehydration, diabetes, and Alzheimer's disorder. It can be treated with the support of salivary pens or stimulants, artificial saliva, prescribed medications, and home remedies, including sipping water and moisturizing lips. Apart from this, the early diagnosis of salivary glands by practitioners and the usage of recommended mouth moisturizing products, such as over-the-counter (OTC) rinsing, can assist in lubricating the mouth. These treatments alleviate discomfort, prevent severe complications, fix taste disorders, and mitigate bad breath and taste disorders. Consequently, xerostomia therapeutics are used across several hospitals and clinics to deal with decreased salivary gland function.

Xerostomia (Dry Mouth Disease) Therapeutics Market Trends:

The increasing incidences of dry mouth, especially amongst the geriatric population, due to medicine side-effects of radiotherapy and chemotherapy and the rising need for dry mouth relief products are primarily driving the market growth. Additionally, the growing uptake of several prescription-based toothpaste, vitamin gummies, and medicines for treating Sjogren's syndrome, Alzheimer's diseases, and human immunodeficiency virus (HIV) that cause xerostomia is acting as another growth-inducing factor. In line with this, the rising consumer awareness regarding the early diagnosis of xerostomia, significant enhancements in healthcare expenditure, and the advent of diverse diagnostic technologies are propelling the market growth. Moreover, the favorable initiatives being commenced by governments to sensitize consumers regarding the xerostomia disease, its symptoms, causes, and treatments are impelling the market growth. Apart from this, the easy availability of various therapeutic drugs and ongoing research and development (R&D) activities are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global xerostomia (dry mouth disease) therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

Artificial Saliva/Saliva Substitutes

Salivary Stimulants

Breakup by Drug Type:

OTC

Prescription

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

Key Questions Answered in This Report

  • 1. How big is the global xerostomia (dry mouth disease) therapeutics market?
  • 2. What is the expected growth rate of the global xerostomia (dry mouth disease) therapeutics market during 2024-2032?
  • 3. What are the key factors driving the global xerostomia (dry mouth disease) therapeutics market?
  • 4. What has been the impact of COVID-19 on the global xerostomia (dry mouth disease) therapeutics market?
  • 5. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on type?
  • 6. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the drug type?
  • 7. What is the breakup of the global xerostomia (dry mouth disease) therapeutics market based on the distribution channel?
  • 8. What are the key regions in the global xerostomia (dry mouth disease) therapeutics market?
  • 9. Who are the key players/companies in the global xerostomia (dry mouth disease) therapeutics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Xerostomia (Dry Mouth Disease) Therapeutics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Artificial Saliva/Saliva Substitutes
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Salivary Stimulants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 OTC
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Prescription
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacy
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 3M Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Biotene (GSK plc)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Parnell Pharmaceuticals Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Quest Products LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Saliwell Ltd
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sun Pharmaceutical Industries Limited
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 West-Ward Pharmaceutical (Hikma Pharmaceuticals plc)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio

List of Figures

  • Figure 1: Global: Xerostomia Therapeutics Market: Major Drivers and Challenges
  • Figure 2: Global: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Xerostomia Therapeutics Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Xerostomia Therapeutics Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Xerostomia Therapeutics Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Xerostomia Therapeutics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Xerostomia Therapeutics (Artificial Saliva/Saliva Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Xerostomia Therapeutics (Salivary Stimulants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Xerostomia Therapeutics (Salivary Stimulants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Xerostomia Therapeutics (OTC) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Xerostomia Therapeutics (OTC) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Xerostomia Therapeutics (Prescription) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Xerostomia Therapeutics (Prescription) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Xerostomia Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Xerostomia Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Xerostomia Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Xerostomia Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Xerostomia Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Xerostomia Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Xerostomia Therapeutics Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Xerostomia Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Xerostomia Therapeutics Industry: SWOT Analysis
  • Figure 72: Global: Xerostomia Therapeutics Industry: Value Chain Analysis
  • Figure 73: Global: Xerostomia Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Xerostomia Therapeutics Market: Key Industry Highlights 2023 and 2032
  • Table 2: Global: Xerostomia Therapeutics Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Xerostomia Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 4: Global: Xerostomia Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Xerostomia Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Xerostomia Therapeutics Market: Competitive Structure
  • Table 7: Global: Xerostomia Therapeutics Market: Key Players